Correlation Between Ikena Oncology and Rezolute

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Rezolute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Rezolute into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and Rezolute, you can compare the effects of market volatilities on Ikena Oncology and Rezolute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Rezolute. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Rezolute.

Diversification Opportunities for Ikena Oncology and Rezolute

0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Ikena and Rezolute is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Rezolute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rezolute and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Rezolute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rezolute has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Rezolute go up and down completely randomly.

Pair Corralation between Ikena Oncology and Rezolute

Given the investment horizon of 90 days Ikena Oncology is expected to generate 0.43 times more return on investment than Rezolute. However, Ikena Oncology is 2.3 times less risky than Rezolute. It trades about 0.04 of its potential returns per unit of risk. Rezolute is currently generating about -0.1 per unit of risk. If you would invest  171.00  in Ikena Oncology on September 1, 2024 and sell it today you would earn a total of  2.00  from holding Ikena Oncology or generate 1.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Ikena Oncology  vs.  Rezolute

 Performance 
       Timeline  
Ikena Oncology 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Ikena Oncology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Ikena Oncology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Rezolute 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Rezolute are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating essential indicators, Rezolute may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Ikena Oncology and Rezolute Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ikena Oncology and Rezolute

The main advantage of trading using opposite Ikena Oncology and Rezolute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Rezolute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rezolute will offset losses from the drop in Rezolute's long position.
The idea behind Ikena Oncology and Rezolute pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets